|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.100 USD | +7.84% |
|
-14.06% | -95.64% |
| 24/11 | Jaguar Health, Inc. announced that it has received $10.81 million in funding | CI |
| 21/11 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
EPS & Dividend: Jaguar Health, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3,37,500 | -1,32,750 | -54,270 | -2,685 | -130.7 | -10.11 | -3.125 | -0.4 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 2,75,059.062 | 1,16,999.854 | 9,776.238 | 227.100 | 25.250 | 1.100 | 1.100 | 1.100 |
| Nbr of stocks (in thousands) | 0.31 | 0.41 | 1.34 | 33.8 | 472 | 4,097 | - | - |
| Announcement Date | 31/03/21 | 11/03/22 | 24/03/23 | 01/04/24 | 31/03/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Jaguar Health, Inc.
| 06/04/2026 | Q4 2025 Earnings Release (Projected) |
| 18/05/2026 | Q1 2026 Earnings Release (Projected) |
| 13/08/2026 | Q2 2026 Earnings Release (Projected) |
| 18/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | -0.11x | - | -0.04x | |
| 0.58% | 0.66% | 44.35x | 33.4x | 14.69x | |
| 2.55% | 2.64% | 19.32x | 6.21x | 5.42x | |
| 2.85% | 2.97% | 53.42x | -552.17x | 7.55x | |
| 3.19% | 3.25% | 17.98x | 6.42x | 4.53x | |
| 1.79% | 1.88% | 27.19x | 6.14x | 5.15x | |
| 3.07% | 3.19% | 18.4x | 5.77x | 4.98x | |
| 3.21% | 3.35% | 13.04x | 4.65x | 4.26x | |
| 3.81% | 3.78% | 13.25x | 7.24x | 4.74x | |
| 2.81% | 2.97% | 25.99x | 20.55x | 6.27x | |
| Average | 2.65% | 2.74% | 23.28x | -51.31x | 5.76x | |
| Weighted average by Cap. | 2.23% | 2.32% | 30.31x | -53.74x | 7.99x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition